marginally significantp = 0.06
Flavanones showed a marginally significant trend ( p for trend =0.05), with the highest intake quartile approaching statistical significance (OR = 0 .74, 95% CI: 0.55–1.01, p = 0.06).
Flavanones showed a marginally significant trend ( p for trend =0.05), with the highest intake quartile approaching statistical significance (OR = 0 .74, 95% CI: 0.55–1.01, p = 0.06).
Hyperlipidemia status demonstrated a highly significant interaction effect ( p for interaction <0.0001), where individuals without hyperlipidemia (OR = 0 .75, 95%CI: 0.66–0.86) experienced a 25% reduction in hypertension risk from flavonoid intake, while those with hyperlipidemia (OR = 0 .99, 95%CI: 0.93–1.04) received virtually no protective benefit.
Similarly, cardiovascular disease status showed a significant interaction ( p for interaction = 0.01), with those free of cardiovascular disease (OR = 0 .91, 95%CI: 0.86–0.96) demonstrating protective effects, whereas patients with cardiovascular disease (OR = 1 .26, 95%CI: 0.97–1.63) showed a trend toward increased risk, though not reaching statistical significance.